Theracryf Plc (FRA:8EV)

Theracryf Balance Sheet

Financials in millions GBP. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	2.11	2	5	4.51	5.59
Short-Term Investments	2.01	-	-	4.52	6
Cash & Short-Term Investments	4.11	2	5	9.03	11.59
Cash Growth	105.29%	-59.92%	-44.63%	-22.11%	180.63%
Accounts Receivable	0.39	0.4	-	-	-
Other Receivables	0.63	0.58	1.02	0.48	0.65
Receivables	1.01	0.97	1.02	0.48	0.65
Prepaid Expenses	0.04	0.05	0.11	0.07	0.1
Total Current Assets	5.17	3.03	6.13	9.58	12.35
Property, Plant & Equipment	-	-	0	0.01	0.01
Other Intangible Assets	2.46	0.03	0.04	0.05	0.07
Total Assets	7.63	3.06	6.17	9.64	12.42
Accounts Payable	0.11	0.33	0.4	0.07	0.41
Accrued Expenses	0.13	0.32	0.39	0.32	0.17
Current Income Taxes Payable	0.02	0.03	0.03	0.02	0.03
Other Current Liabilities	1.01	0.05	0.01	0	0
Total Current Liabilities	1.66	0.72	0.83	0.41	0.61
Other Long-Term Liabilities	-0	-0	-	-	-
Total Liabilities	1.66	0.72	0.83	0.41	0.61
Common Stock	5.32	0.69	0.69	0.69	0.69
Additional Paid-In Capital	28.7	27.87	27.87	27.87	27.87
Retained Earnings	-30.43	-28.92	-25.79	-21.89	-19.17
Comprehensive Income & Other	2.38	2.7	2.58	2.56	2.43
Shareholders' Equity	5.97	2.34	5.34	9.23	11.81
Total Liabilities & Equity	7.63	3.06	6.17	9.64	12.42
Net Cash (Debt)	4.11	2	5	9.03	11.59
Net Cash Growth	105.29%	-59.92%	-44.63%	-22.11%	180.63%
Net Cash Per Share	0.01	0.01	0.02	0.03	0.08
Filing Date Shares Outstanding	2,130	274.89	274.89	274.89	274.89
Total Common Shares Outstanding	2,130	274.89	274.89	274.89	274.89
Working Capital	3.51	2.31	5.3	9.17	11.74
Book Value Per Share	0.00	0.01	0.02	0.03	0.04
Tangible Book Value	3.51	2.31	5.3	9.17	11.75
Tangible Book Value Per Share	0.00	0.01	0.02	0.03	0.04
Machinery	-	-	0.01	0.01	0.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.